Literature DB >> 2725510

Identification and characterization of PF4varl, a human gene variant of platelet factor 4.

C J Green1, R S Charles, B F Edwards, P H Johnson.   

Abstract

A synthetic DNA probe designed to detect coding sequences for platelet factor 4 and connective tissue-activating peptide III (two human platelet alpha-granule proteins) was used to identify several similar sequences in total human DNA. Sequence analysis of a corresponding 3,201-base-pair EcoRI fragment isolated from a human genomic library demonstrated the existence of a variant of platelet factor 4, designated PF4var1. The gene for PF4var1 consisted of three exons and two introns. Exon 1 coded for a 34-amino-acid hydrophobic leader sequence that had 70% sequence homology with the leader sequence for PF4 but, in contrast, contained a hydrophilic amino-terminal region with four arginine residues. Exon 2 coded for a 42-amino-acid segment that was 100% identical with the corresponding segment of the mature PF4 sequence containing the amino-terminal and disulfide-bonded core regions. Exon 3 coded for the 28-residue carboxy-terminal region corresponding to a domain specifying heparin-binding and cellular chemotaxis. However, PF4var1 had amino acid differences at three positions in the lysine-rich carboxy-terminal end that were all conserved among human, bovine, and rat PF4s. These differences should significantly affect the secondary structure and heparin-binding properties of the protein based on considerations of the bovine PF4 crystal structure. By comparing the PF4var1 genomic sequence with the known human cDNA and the rat genomic PF4-coding sequences, we identified potential genetic regulatory regions for PF4var1. Rat PF4 and human PF4var1 genes had identical 18-base sequences 5' to the promoter region. The intron positions appeared to correspond approximately to the boundaries of the protein functional domains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725510      PMCID: PMC362561          DOI: 10.1128/mcb.9.4.1445-1451.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

2.  Prediction of the secondary structure of platelet factor 4 and beta-thromboglobulin from their amino acid sequences.

Authors:  J W Lawler
Journal:  Thromb Res       Date:  1981 Jan 1-15       Impact factor: 3.944

3.  Bovine platelet antiheparin protein: platelet factor 4.

Authors:  R E Ciaglowski; J W Snow; D A Walz
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Primary structure of human platelet factor 4.

Authors:  D A Walz; V Y Wu; R de Lamo; H Dene; L E McCoy
Journal:  Thromb Res       Date:  1977-12       Impact factor: 3.944

5.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

6.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

7.  Complete covalent structure of human platelet factor 4.

Authors:  F J Morgan; G S Begg; C N Chesterman
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin.

Authors:  A Richmond; E Balentien; H G Thomas; G Flaggs; D E Barton; J Spiess; R Bordoni; U Francke; R Derynck
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  12 in total

Review 1.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

Review 2.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

3.  Polymerase chain reaction (PCR) for detection of PstI polymorphism in the human PF4 gene.

Authors:  B Ramachandran; E F Rappaport; S Surrey; M Poncz; E Schwartz
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

Review 4.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

5.  Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.

Authors:  K Aneja; G Jalagadugula; G Mao; A Singh; A K Rao
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

6.  Identification of three related human GRO genes encoding cytokine functions.

Authors:  S Haskill; A Peace; J Morris; S A Sporn; A Anisowicz; S W Lee; T Smith; G Martin; P Ralph; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.

Authors:  Sofie Struyf; Laura Salogni; Marie D Burdick; Jo Vandercappellen; Mieke Gouwy; Sam Noppen; Paul Proost; Ghislain Opdenakker; Marc Parmentier; Craig Gerard; Silvano Sozzani; Robert M Strieter; Jo Van Damme
Journal:  Blood       Date:  2010-10-27       Impact factor: 22.113

8.  Structures of human genes coding for cytokine LD78 and their expression.

Authors:  M Nakao; H Nomiyama; K Shimada
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer.

Authors:  Lei Zhang; Guangping Li; Hongxin Zhang; Huaqun Liu; Songlin Li; Yanan Wang; Huisheng Qi
Journal:  Cancer Manag Res       Date:  2022-06-07       Impact factor: 3.602

10.  Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues.

Authors:  P Tekamp-Olson; C Gallegos; D Bauer; J McClain; B Sherry; M Fabre; S van Deventer; A Cerami
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.